Europe’s defence and munitions group CSG ended the trading week at €14.42, a 2.75% decline on the day that extended the monthly slide to nearly 10% and the weekly loss to about 4%. The stock now trades barely 5.7% above its 52-week low of €13.65 and a staggering 60% below the January peak of €36.05. Two significant positive developments — a promotion to Euronext’s AMX mid-cap index and newly disclosed fuse contracts from NATO customers — have failed to stem the selling pressure.
Euronext announced on June 9 that CSG would join the AMX index, effective after the close on June 19. Index inclusion typically widens the shareholder base as tracking funds adjust portfolios, but in this case the news triggered no sustained buying. Nor did the disclosure of two contracts for mechanical and electronic fuses for large-calibre ammunition, awarded by two European NATO customers. The combined value runs in the high double-digit millions of euros, with deliveries expected to start later this year. To produce the electronic fuses, CSG has formed a Slovak joint venture with South Africa’s Reunert called Fuchs Electronics Europe, in which Reunert holds 51% and CSG 49%. The project is backed by a binding initial order covering the first three years.
The operational picture remains fundamentally solid even as the share price wilts. In the first quarter of fiscal 2026, revenue climbed 13.8% year-on-year to €1.544 billion, while operating EBIT rose 8.7% to €372 million. The Defence Systems segment was the standout, with revenue surging 26.5% to €1.251 billion. The Ammo+ business, however, contracted 20.5% to €291 million, mainly due to weak demand in the US civilian market — a headwind the company says improved toward the end of the quarter. The order backlog swelled to €17 billion at March 31, driven largely by Land Systems, and the total sales pipeline stands at €27 billion, underscoring sustained NATO demand. Management reaffirmed its full-year guidance: revenue between €7.4 billion and €7.6 billion and an operating EBIT margin of 24% to 25%.
Should investors sell immediately? Or is it worth buying CSG?
Technically, the stock remains under duress. The relative strength index hovers around 32, with one reading at 32.1 and another at 31.9 — both indicating oversold conditions, yet no reversal signal has emerged. The share price sits more than 22% below its 50-day moving average of €18.61, a bearish configuration that the market has not yet challenged. Annualized 30-day volatility stands at 62.46%, reflecting the turbulence that has gripped the name since the spring sell-off.
Investors now pin their hopes on the half-year report due August 7. That is where CSG must demonstrate that its record backlog translates into realised revenue and margins, and that the ramp-up of ammunition production stays on track. Until then, the disconnect between a €17 billion order book and a stock trading near its yearly low remains the central puzzle for shareholders, one that even an index upgrade and fresh NATO contracts have so far failed to solve.
Ad
CSG Stock: Buy or Sell?! New CSG Analysis from June 13 delivers the answer:
The latest CSG figures speak for themselves: Urgent action needed for CSG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 13.
CSG: Buy or sell? Read more here...
